# Post-Task Self-Review - Stage 16 Learning Evidence Quality Improvement

## Completed Task

Stage 16 repaired project-state history after Stage 15 and improved learning
evidence/data-quality observability without training, model expansion,
checkpointing, training artifacts, PPO/MAPPO, COMA, Transformer, reward-weight
calibration, final tau selection, or v5 migration.

## Intended Desired State

The desired state was an in-memory evidence-quality builder and report covering
tau feasible, near-threshold, hard infeasible, sparse/full resource contrast,
weak-primary/center-primary contrast, interference/resource penalty proxy, real
multi-step actor-safe sequence evidence, and rebuilt add/remove/keep
edge-delta targets.

## Actual Achieved State

Stage 16 now has:

- `59` evidence rows and `850` edge-delta targets.
- `30` rows at or above `tau_requirement_min=0.9`.
- `17` near-threshold rows.
- `5` hard infeasible rows.
- `8` sparse feasible topology rows.
- `2` full graph resource-dominated rows.
- a real mobility-derived actor-safe sequence with `time_step = 0, 1, 2`.
- edge-delta counts for add edge, remove edge, and keep edge.
- explicit report answers that supervised rerun and scale-up training remain
  blocked.

## Evidence

- `python -m pytest -q`: `678 passed`.
- `python harness\scripts\validate_tasks.py`: passed with `72` tasks.
- Targeted Stage 16 tests: `11 passed`.
- Stage 16 builder writes no `result_save` artifact.
- Stage 16 source scan rejects training/checkpoint/model-expansion patterns.

## Gates Passed

- Evidence coverage gate.
- Edge-delta rebuild gate.
- Actor leakage gate.
- Real multi-step actor-safe sequence gate.
- No artifact write gate.
- No training/checkpoint/model-expansion gate.
- Harness registry validation gate.

## Gates Deferred

- Scale-up training gate.
- Stage 11-15 rerun gate.
- Larger scenario diversity gate.
- Actor-label disambiguation gate.

## New Risks

The evidence set is improved but still deterministic and small. The report
detects identical local observations with contradictory labels, so actor-local
features are still not sufficient to fully disambiguate labels.

## Regressions Checked

Existing Stage 7-15 contracts remained green under the full test suite.
`v5` was not modified, and no training artifact or checkpoint path was added by
Stage 16.

## Required Stage 16 Questions

Does Stage 16 improve evidence quality? Yes. It adds tau-feasible,
near-threshold, hard infeasible, sparse/full, primary-contrast,
interference/resource proxy, real multi-step, and edge-delta balance sensors.

Is scale-up training still blocked? Yes. The report explicitly keeps
`scale_up_training_allowed` false because contradictory local labels and small
deterministic coverage remain.

Should the next step be rerun Stage 11-15 on improved evidence, or continue
evidence expansion? Continue evidence expansion first. Rerunning Stage 11-15
now would mostly re-measure known label ambiguity.

## Candidate Next Tasks

- Continue evidence expansion with more real scenario/mobility sequences and
  conflict/resource conditions.
- Add a label-disambiguation analysis that separates topology-state-dependent
  labels from actor-local edge features.
- Only after owner decision, rerun Stage 11-15 on the expanded evidence.

## Recommended Next Task

`stage_16_continue_evidence_expansion_before_rerun_stage11_to_stage15`.

## Owner Decision Required

Yes. Stage 16 does not self-authorize scale-up training or Stage 11-15 reruns.
